Onyx Bridge Wealth Group LLC
Source: SEC Form 13F · as of Mar 2026Onyx Bridge Wealth Group LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $12.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$12.5M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 20,346 | $2.4M |
| PMPhilip Morris International Inc | 10,152 | $1.7M |
| LLYELI LILLY & Co | 1,523 | $1.4M |
| JNJJOHNSON & JOHNSON | 5,690 | $1.4M |
| PFEPFIZER INC | 49,141 | $1.4M |
| ABBVAbbVie Inc. | 6,154 | $1.3M |
| AMGNAMGEN INC | 1,935 | $681K |
| GILDGILEAD SCIENCES, INC. | 4,586 | $639K |
| BMYBRISTOL MYERS SQUIBB CO | 8,155 | $495K |
| ABTABBOTT LABORATORIES | 4,142 | $425K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 494 | $221K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,629 | $200K |
| SIGASIGA TECHNOLOGIES INC | 13,000 | $70K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 19,200 | $59K |
| AKBAAkebia Therapeutics, Inc. | 15,000 | $21K |
| GERNGERON CORP | 10,000 | $15K |
| TLPHTALPHERA, INC. | 11,500 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.